While the clinical case for cardiac PET is compelling, it also has to be feasible from a financial and logistical standpoint.

Drinking water contaminated with inorganic arsenic could increase young adults’ risk of CVD by thickening the heart’s left ventricular (LV) wall and triggering hypertrophy, researchers reported in Circulation: Cardiovascular Imaging May 7.

Omron Healthcare launched its latest innovation, Complete, May 1, marking the first time a blood pressure (BP) monitor with electrocardiogram (ECG) capabilities has hit the commercial market.

Cardio-oncology has emerged as an area of rapid growth in the medical community in recent years, owing in large part to an increasing population of cancer survivors.

Catheter-directed therapy (CDT) is being used to treat pulmonary embolism (PE) more and more by healthcare providers, according to new research published in the Journal of Vascular and Interventional Radiology.

The Radiological Society of North America (RSNA) on April 25 launched the first issue of its newest online journal, Radiology: Cardiothoracic Imaging.

Guerbet, a medical imaging company out of Villepinte, France, this week announced it received CE mark approval for its SeQure and DraKon devices, two microcatheters that facilitate the intra-arterial delivery of therapies and embolic materials to peripheral vessels.

A study of nearly 4,000 patients with coronary artery disease (CAD) has linked blood pressure variability (BPV) between clinic visits to significantly greater progression of coronary atheroma and major adverse events, suggesting BP stability might be an important factor in CAD care.